1349.HK
Price:
$2.6
Market Cap:
$800.65M
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products. It offers genetic engineering platform drugs, including CD30-DM1 antibody-drug conjugate (ADC), which is in Phase I clinical trials for tumors; Trop2-SN38 ADC that is in Phase I clinical trials for triple negative, breast, bladder, gastric, and other tumors; Trop2-BB05 ADC that is in pre-clinical studies for lung cancer and triple negative breast cancer; and HER2 ADC that has completed pre-clinical research for metastatic breast and gastric cancers. The company also provides photodynamic technical platform drugs, such as hemoporfin...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-08-13
Stock Exchange
HKSE
Ticker
1349.HK
According to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 65.00. This represents a change of -70.94% compared to the average of 223.68 of the last 4 quarters.
The mean historical PE Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. over the last ten years is 186.59. The current 65.00 PE Ratio has changed 3.38% with respect to the historical average. Over the past ten years (40 quarters), 1349.HK's PE Ratio was at its highest in in the March 2019 quarter at 1.74K. The PE Ratio was at its lowest in in the March 2020 quarter at -460.07.
Average
186.59
Median
175.15
Minimum
62.34
Maximum
453.61
Discovering the peaks and valleys of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 129.48%
Maximum Annual PE Ratio = 453.61
Minimum Annual Increase = -50.14%
Minimum Annual PE Ratio = 62.34
Year | PE Ratio | Change |
---|---|---|
2024 | 200.09 | 129.48% |
2023 | 87.20 | 39.88% |
2022 | 62.34 | -9.39% |
2021 | 68.80 | -33.78% |
2020 | 103.89 | -30.84% |
2019 | 150.21 | -33.59% |
2018 | 226.19 | -50.14% |
2017 | 453.61 | 84.24% |
2016 | 246.21 | -7.92% |
2015 | 267.38 | -7.41% |
The current PE Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
116.54
5-year avg
104.46
10-year avg
186.59
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s PE Ratio is greater than Dynagreen Environmental Protection Group Co., Ltd. (15.74), less than Shanghai Fudan Microelectronics Group Company Limited (67.17), greater than China Pioneer Pharma Holdings Limited (15.78), greater than LifeTech Scientific Corporation (27.91), greater than PW Medtech Group Limited (9.88),
Company | PE Ratio | Market cap |
---|---|---|
15.74 | $9.35B | |
67.17 | $32.55B | |
15.78 | $2.60B | |
27.91 | $6.82B | |
9.88 | $1.63B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.'s PE Ratio?
How is the PE Ratio calculated for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)?
What is the highest PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)?
What is the 3-year average PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)?
What is the 5-year average PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)?
How does the current PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) compare to its historical average?